These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 25468285)

  • 21. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation.
    Grill S; Fallah M; Leach RJ; Thompson IM; Hemminki K; Ankerst DP
    J Clin Epidemiol; 2015 May; 68(5):563-73. PubMed ID: 25684153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
    Jin HJ; Jung S; DebRoy AR; Davuluri RV
    Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genome-wide assessment of variability in human serum metabolism.
    Hong MG; Karlsson R; Magnusson PK; Lewis MR; Isaacs W; Zheng LS; Xu J; Grönberg H; Ingelsson E; Pawitan Y; Broeckling C; Prenni JE; Wiklund F; Prince JA
    Hum Mutat; 2013 Mar; 34(3):515-24. PubMed ID: 23281178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer: Clinical hallmarks in whole cancer genomes.
    Imielinski M; Rubin MA
    Nat Rev Clin Oncol; 2017 May; 14(5):265-266. PubMed ID: 28374788
    [No Abstract]   [Full Text] [Related]  

  • 26. Highlights from the prostate cancer genome report.
    Tan SH; Petrovics G; Srivastava S
    Asian J Androl; 2011 Sep; 13(5):659-60. PubMed ID: 21666698
    [No Abstract]   [Full Text] [Related]  

  • 27. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.
    Gu L; Frommel SC; Oakes CC; Simon R; Grupp K; Gerig CY; Bär D; Robinson MD; Baer C; Weiss M; Gu Z; Schapira M; Kuner R; Sültmann H; Provenzano M; ; Yaspo ML; Brors B; Korbel J; Schlomm T; Sauter G; Eils R; Plass C; Santoro R
    Nat Genet; 2015 Jan; 47(1):22-30. PubMed ID: 25485837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics of prostate cancer risk.
    Pomerantz MM; Freedman ML
    Mt Sinai J Med; 2010; 77(6):643-54. PubMed ID: 21105126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A genome-wide pleiotropy scan for prostate cancer risk.
    Panagiotou OA; Travis RC; Campa D; Berndt SI; Lindstrom S; Kraft P; Schumacher FR; Siddiq A; Papatheodorou SI; Stanford JL; Albanes D; Virtamo J; Weinstein SJ; Diver WR; Gapstur SM; Stevens VL; Boeing H; Bueno-de-Mesquita HB; Barricarte Gurrea A; Kaaks R; Khaw KT; Krogh V; Overvad K; Riboli E; Trichopoulos D; Giovannucci E; Stampfer M; Haiman C; Henderson B; Le Marchand L; Gaziano JM; Hunter DJ; Koutros S; Yeager M; Hoover RN; ; Chanock SJ; Wacholder S; Key TJ; Tsilidis KK
    Eur Urol; 2015 Apr; 67(4):649-57. PubMed ID: 25277271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive analysis of genome-wide association studies to identify prostate cancer susceptibility loci for the Romanian population.
    Rădăvoi GD; Pricop C; Jinga V; Mateş D; Rădoi VE; Jinga M; Ursu RI; Bratu OG; Mischianu DL; Iordache P
    Rom J Morphol Embryol; 2016; 57(2):467-75. PubMed ID: 27516020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of genome-wide and replication association studies on prostate cancer.
    Liu H; Wang B; Han C
    Prostate; 2011 Feb; 71(2):209-24. PubMed ID: 20690139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genome-wide association study(GWAS) and genetic risk of prostate cancer].
    Nakagawa H; Akamatsu S; Takata R
    Nihon Rinsho; 2016 Jan; 74(1):34-9. PubMed ID: 26793876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical uncertainty of prostate cancer genetic risk panels.
    Pomerantz M; Freedman ML
    Sci Transl Med; 2013 Apr; 5(182):182ed6. PubMed ID: 23616119
    [No Abstract]   [Full Text] [Related]  

  • 34. Pleiotropy in aggressive prostate cancer?
    Cox A
    Eur Urol; 2015 Apr; 67(4):658-9. PubMed ID: 25468285
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.